NewsBenzinga礼来公布 TRIUMPH-2 详细结果；TRIUMPH-2 中患有肥胖和 2 型糖尿病、使用 Retatrutide 12 毫克的参与者在 80 周内平均减重 49.6 磅；Retatrutide 12 毫克在 BMI≥35 组中实现 60.8 磅减重；计划于 2027 年第一季度提交 Retatrutide 的生物制品许可申请 礼来公布 TRIUMPH-2 详细结果；TRIUMPH-2 中患有肥胖和 2 型糖尿病、使用 Retatrutide 12 毫克的参与者在 80 周内平均减重 49.6 磅；Retatrutide 12 毫克在 BMI≥35 组中实现 60.8 磅减重；计划于 2027 年第一季度提交 Retatrutide 的生物制品许可申请 Benzinga 2026.09.29 22:07 (GMT+0) Open on Benzinga Other news Here's How Much $1000 Invested In Gold Fields 5 Years Ago Would Be Worth Today If You Invested $100 In Philip Morris Intl Stock 5 Years Ago, You Would Have This Much Today Robinhood’s Next Big Bet: AI Bots That Trade While You Sleep He Was Rejected by Goldman Out of College. Now He’s Poised to Run the Bank. Here’s How Much You Would Have Made Owning STMicroelectronics Stock In The Last 15 Years If You Invested $1000 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
